18 June 2013
Keywords: acadia, initiates, ph, iib, trial, acp-104, usa
Article | 02 July 2007
The USA's Acadia Pharmaceuticals has initiated a Phase IIb trial designed to evaluate the safety and efficacy of its atypical
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 July 2007
© 2013 thepharmaletter.com